(VLTO) Veralto - Overview
Stock: Water Analytics, Water Treatment, Marking Coding, Color
| Risk 5d forecast | |
|---|---|
| Volatility | 25.5% |
| Relative Tail Risk | -3.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -14.97 |
| Character TTM | |
|---|---|
| Beta | 0.680 |
| Beta Downside | 0.673 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.27 |
EPS (Earnings per Share)
Revenue
Description: VLTO Veralto February 11, 2026
Veralto Corporation (NYSE:VLTO) delivers water-focused analytics and treatment solutions alongside marking, coding, and packaging-color technologies through its two operating segments: Water Quality (WQ) and Product Quality & Innovation (PQI).
The WQ segment, anchored by the Hach, Trojan Technologies, and ChemTreat brands, provides precision instruments, chemical reagents, digital platforms, and treatment systems for residential, commercial, municipal, industrial, research, and natural-resource applications. In FY 2024 the segment generated roughly $1.2 billion in revenue, representing about 60 % of total sales and delivering an adjusted EBITDA margin of 13 %.
The PQI segment, marketed under Videojet, Linx, Esko, X-Rite, and Pantone, offers marking and coding hardware, inline printing solutions, design and imaging software, and color-management services for packaged goods, pharmaceuticals, food & beverage, and other industrial sectors. PQI contributed about $800 million in FY 2024 revenue, with a 10 % adjusted EBITDA margin, and has seen double-digit growth in its software-as-a-service (SaaS) offerings.
Key macro drivers include heightened regulatory scrutiny on water quality (e.g., EPA tightening discharge limits), rising global water scarcity that fuels demand for treatment technologies, and accelerating sustainability mandates that push manufacturers toward advanced packaging-marking and color-management solutions. The global water-analytics market is projected to expand at a CAGR of ~7 % through 2030, while the industrial packaging marking market is expected to grow ~5 % annually, both trends that underpin Veralto’s growth outlook.
As of the latest quarterly filing (Q3 2024), Veralto’s market capitalization stood near $4.2 billion, with a forward-looking earnings-per-share estimate of $2.30 and a price-to-sales multiple of 2.1, indicating modest valuation relative to peers in the Environmental & Facilities Services sub-industry.
For a deeper, data-rich perspective on Veralto’s valuation and risk profile, you may find ValueRay’s analyst notes worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 940.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 25.00% < 20% (prev 21.99%; Δ 3.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.08b > Net Income 940.0m |
| Net Debt (642.0m) to EBITDA (1.35b): 0.48 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.5m) vs 12m ago 0.08% < -2% |
| Gross Margin: 59.95% > 18% (prev 0.60%; Δ 5935 % > 0.5%) |
| Asset Turnover: 78.06% > 50% (prev 81.06%; Δ -3.00% > 0%) |
| Interest Coverage Ratio: 13.22 > 6 (EBITDA TTM 1.35b / Interest Expense TTM 96.0m) |
Altman Z'' 3.74
| A: 0.18 (Total Current Assets 3.43b - Total Current Liabilities 2.06b) / Total Assets 7.69b |
| B: 0.20 (Retained Earnings 1.52b / Total Assets 7.69b) |
| C: 0.18 (EBIT TTM 1.27b / Avg Total Assets 7.05b) |
| D: 0.68 (Book Value of Equity 3.11b / Total Liabilities 4.59b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -3.04
| DSRI: 1.04 (Receivables 897.0m/812.0m, Revenue 5.50b/5.19b) |
| GMI: 0.99 (GM 59.95% / 59.60%) |
| AQI: 0.88 (AQ_t 0.52 / AQ_t-1 0.59) |
| SGI: 1.06 (Revenue 5.50b / 5.19b) |
| TATA: -0.02 (NI 940.0m - CFO 1.08b) / TA 7.69b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of VLTO shares?
Over the past week, the price has changed by +0.95%, over one month by -8.28%, over three months by -5.03% and over the past year by -6.56%.
Is VLTO a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VLTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.1 | 18.3% |
| Analysts Target Price | 110.1 | 18.3% |
VLTO Fundamental Data Overview February 21, 2026
P/E Forward = 26.5957
P/S = 4.2404
P/B = 7.5129
P/EG = 3.7486
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 23.98b USD (23.33b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 23.65x (Enterprise Value 23.98b / FCF TTM 1.01b)
FCF Yield = 4.23% (FCF TTM 1.01b / Enterprise Value 23.98b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.12 (Enterprise Value 23.98b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.01% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.92% (NOPAT 1.10b / Invested Capital 5.26b)
WACC = 7.62% (E(23.33b)/V(26.01b) * Re(8.42%) + D(2.67b)/V(26.01b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF Debug] Terminal Value 79.53% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
Fair Price DCF = 73.42 (EV 18.87b - Net Debt 642.0m = Equity 18.23b / Shares 248.3m; r=7.62% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 92.25 | EPS CAGR: 11.63% | SUE: 3.65 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg30d=+0.011 | Revisions Net=+5 | Growth EPS=+7.3% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=4.55 | Chg30d=-0.000 | Revisions Net=+3 | Growth EPS=+8.7% | Growth Revenue=+5.3%